Industry news
GSK declines to sell older brand drugs
As announced at the GlaxoSmithKline (GSK) 2nd quarter results in July, GSK started a process to consider the divestment of certain North American and European brands in its Established Products Portfolio. The Company has evaluated all bids received and has concluded, consistent with its key criteria of maximising shareholder value, not to pursue divestment of these products.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.